REDWOOD CITY, Calif., June 06, 2018 — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that its Bioflux device has won the prestigious MedTech Breakthrough Award 2018 for Best Remote Patient Monitoring Solution. MedTech Breakthrough, an independent organization that recognizes the top companies, technologies and products in the global health and medical technology market, designed the awards to recognize those companies that have succeeded in pushing ingenuity and exemplify the best healthcare technology solutions across the globe.
“It is an honor to be selected the best Remote Patient Monitoring Solution by MedTech Breakthrough given the considerable competition and number of entries this year,” said Mr. Waqaas Al-Siddiq, Founder and CEO of Biotricity. “We consider this recognition a true testament to the hard work and passion of the Biotricity team and, more importantly, the impact our remote patient monitoring device is expected to have on the lives of patients.”
The Bioflux system is designed to be a complete solution for cardiac monitoring and diagnosis, consisting of the Bioflux device, proprietary software, and a 24/7 monitoring center that merges seamlessly with physicians’ existing platforms and workflows. Unlike traditional cardiac monitoring solutions, Bioflux extends the support a patient receives at a care facility into the patient’s home. The device monitors a patient’s ECG in near real-time, constantly analyzing and collecting data on the device and periodically uploading to the cloud via embedded cellular technology.
“Doctors and patients are eager for solutions that help them harness the power of data to drive better care and value,” said Spencer LaDow, Vice President of Engineering at Biotricity. “We designed the Bioflux system to meet this need by bringing patient-specific insights into a physician’s workflow in real-time, enabling them to better detect and diagnose heart conditions. With earlier detection and diagnosis, effective at-home use, and billing code integration for physicians, Bioflux is expected to positively impact care quality, patient outcomes, and reimbursement.”
The mission of the MedTech Breakthrough Awards is to honor the innovation, hard work and success of the top companies, people, platforms and products in the health, fitness and medical technology industries. This year’s program attracted more than 3,000 nominations for the different award categories from over 10 different countries. All nominations were evaluated by an independent panel of experts within the medical and health industry.